S 2035 (replaced by A 277) – New Jersey
Status: Inactive / DeadYear Introduced: 2020
Link: https://www.njleg.state.nj.us/bill-search/2020/S2035
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Substituted by another Bill
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found